Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
Showing 1,321–1,380 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
…Background Personalized cancer immunotherapies have garnered much interest in recent years, owing to advanceme…
…tion and chemotherapy, 1 and only 10-15% of patients respond to immune checkpoint blockade therapy.2 Personalized vaccination with tumor lysate-pulsed dendritic c…
…rticularly in advanced, relapsed, or refractory cases. Although CAR T cell therapy has shown success in hematologic malignancies, its application …
…Background Adoptive cell therapy (ACT) using T cell receptor-engineered T cells (TCR-T cell) rep…
…l of identifying T cell receptors (TCRs) for the development of TCR-T cell therapies to eliminate p16INK4A- and p14ARF-expressing cancer cells.Metho…
…r these cells to eradicate tumor lesions.Methods To establish a TCR-T cell therapy intended for the treatment of solid cancers, including PDAC and…
…stics.Methods In a prospective cohort of NPC patients receiving induction immunotherapy (pembrolizumab) and concurrent chemoirradiation, we analysed th…
…Background Natural killer (NK) cell-based immunotherapy offers a promising strategy for treating a wide range of hemato…
…) had an upfront CLND; and 31 (48%) had an index node excision (INE) with reflex CLND ultimately performed in 7 patients. The remai…
…Background Adoptive T cell immunotherapy has shown curative potential in cancers once considered untreat…
…Background Chimeric antigen receptor (CAR) T cell therapy has shown promise in relapsed/refractory multiple myeloma (r/rM…
…ell lung cancer (NSCLC) and associated with lack of response to checkpoint blockade immunotherapy. Cell therapies using tumor-infiltrating lymphocytes (TILs) hav…